10:02 AM EDT, 04/03/2025 (MT Newswires) -- Amneal Pharmaceuticals ( AMRX ) said Thursday that the Veterans Administration, UnitedHealthcare (UNH), and CVS Health ( CVS ) have added Parkinson's disease treatment Crexont to their national prescription drug formularies.

The company said the additional coverage increases the total US insurance coverage of Crexont to more than 50% of covered patients from about 30% at the end of 2024. Amneal added it had previously set a target of over 50% coverage by the end of 2025.

Price: 8.10, Change: -0.07, Percent Change: -0.86